| Oral presentation schedule for November 5 (Sat), Day 3 |
| |
|
Kobe International Exhibition Hall No.2 Building |
Portopia Hotel |
Kobe International Conference Center |
Kobe International Exhibition Hall No.1 Building |
Kobe International Exhibition Hall No.2 Building |
|
| |
|
Hall (South) |
Conference Room 3A |
Portopia Hall |
Ohwada A |
Ohwada B |
Ohwada C |
Kairaku 1 |
Kairaku 2 |
Kairaku 3 |
Waraku |
Topaz |
Emerald |
Ikuta |
501+502 |
Digital Poster Session & Commercial Exhibition |
Digital Poster Session & Commercial Exhibition |
|
| |
|
Room 1 |
Room 2 |
Room 3 |
Room 4 |
Room 5 |
Room 6 |
Room 7 |
Room 8 |
Room 9 |
Room 10 |
Room 11 |
Room 12 |
Room 13 |
Room 14 |
Room 15 |
Room 16 |
|
| 8:00 |
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
8:00 |
| 45 |
|
No planned seminars |
Breakfast
Seminar19 Meiji Seika Pharma Co., Ltd.
Salvage Photodynamic therapy (PDT) for patients with local failure after chemoradiotherapy for esophageal cancer |
No planned seminars |
Breakfast
Seminar20 OLYMPUS CORPORATION
Tips for endoscopic observation method in early gastric cancer screening program |
Breakfast
Seminar21 TSUMURA & CO.
Japanese herbal medicine for GI diseases, which is spreading across the entire globe- Evidence and possibility of herb treatments for functional GI diseases - |
Breakfast
Seminar22 TAIHO PHARMACEUTICAL CO., LTD.
The role of surgeons for further improvement of prognosis of patients with colorectal liver metastasis |
Breakfast
Seminar23 Astellas Pharma Inc.
Evidence-based management of IBS |
Breakfast
Seminar24 Cook Japan Inc.
Resectable Pancreatic Cancer –Roles of endoscopic drainage and ways to improve its outcomes |
Breakfast
Seminar25 Nippon Boehringer Ingelheim Co., Ltd. / Eli Lilly Japan K. K.
NAFLD and Type 2 Diabetes – How Should We Treat? - |
Breakfast
Seminar26 Roche Diagnostics.K.K.
Navigating through the HCV management challenges: from treatment selection to follow-up after SVR |
Breakfast
Seminar27 Novartis Pharma K.K.
GIST Diagnosis and Treatment Update |
Breakfast
Seminar28 FUJIFILM RI Pharma Co., Ltd.
Front line of diagnosis & treatment in GEP-NET -Guide to the nonapproachable NET- |
No planned seminars |
|
|
|
45 |
| 9:00 |
|
|
|
|
|
|
|
|
|
|
|
|
|
9:00 |
| 20 |
|
S5 (JSGS / JSGE / JGES)
Neoadjuvant therapy followed by surgery in esophageal cancer <Video> Chair: Y. Seto
S. Natsugoe |
W16 (JSGE / JGES / JSH / JSGS / JSGCS)
Pathophysiology of IgG4-related disease in gastroenterological lesion Chair: T. Kamisawa
K. Uchida |
Invited Lecture (JGES)
GI mucosal injury and bleeding in the GI induced by anti-thrombotics F. Chan
Chair: A. Shiotani |
W17 (JGES / JSGCS)
Advanced diagnostic endoscopy in the upper GI tract<JGES Featured Session> Chair: T. Kawai
Y. Sakata |
Integrated Program 5(S) (JDDW (JSH / JSGE / JSGS))
Strategy for hepatitis viral infection after curative treatment of HCC Chair: N. Izumi
Y. Ku
S. Kaneko |
PD14 (JSGS / JSGE / JSH)
Strategy for liver metastasis of colo-rectal cancer <Answer pad> Chair: K. Sano
M. Yamamoto |
S7 (JSGS / JSGE / JGES / JSGCS)
Intraductal papillary mucinous neoplasm (IPMN) Update Chair: T. Ohta
M. Nakamura |
Invited Lecture (JGES)
Horizons for Japanese and Saudi collaboration in gastroenterology and hepatology M. A. Almadi
Chair: A. Nakajima |
W19 (JSGE / JGES / JSGS)
Management for deficiency of pancreatic endocrine and exocrine function Chair: T. Ito
M. Unno |
Medicalstaff Program1 (JDDW)
The multidisciplinary team in palliative care Chair: K. Yamaguchi
J. Kawakami |
PD16 (JSGE / JSGS / JSGCS)
Have molecularly targeted agents improved the prognosis in patients with gastrointestinal cancers? Chair: Y. Shinomura
K. Kubota |
W21 (JSGS / JSGE)
Technical pitfalls of transverse colectomy Chair: T. Masaki
Y. Hashiguchi |
Live broadcast
Room |
JDDW 2016 Hands-on seminar 3 (EUS) Coordinator:
K. Hara |
|
Commercial Exhibition |
|
Commercial Exhibition |
20 |
| 30 |
IS-PD1 (JGES)
Globalization of advanced endoscopy: What the world needs from Japan Chair: T. Gotoda
I. Oda |
30 |
| 40 |
| Digital Poster Session (JSGE) |
9:30 | 11:00 |
| Digital Poster Session (JGES) |
9:30 | 11:30 |
| Digital Poster Session (JSGS) |
9:30 | 11:30 |
40 |
| 10:00 |
PD12 (JGES / JSGE / JSGS / JSGCS)
Current management of antithrombotic agents induced gastrointestinal bleeding Chair: Y. Fujiwara
T. Koike |
10:00 |
| 11:00 |
|
11:00 |
| 20 |
|
|
20 |
| 30 |
Lecture by Congress President (JGES)
Advantage of computerized medical records system for clinical research in the gastroenterological endoscopy K. Fujimoto
Chair: T. Yao |
Invited Lecture (JSGE)
Endocrine dysfunction in pancreatic cancer S. T. Chari
Chair: K. Shiratori |
30 |
| 40 |
|
|
40 |
| 12:00 |
Lecture by Board Chair of JGES (JGES)
JGES activities toward globalization and endoscopic training system H. Tajiri
Chair: M. Kaminishi |
12:00 |
| 30 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
30 |
| 13:00 |
Luncheon
Seminar51 Century Medical,Inc.
Metallic stent Up to date. –Hot topics of biliary, duodenum and colonic stenting– |
Luncheon
Seminar52 Mylan EPD G.K.
Open New Era of Constipation Treatment |
No planned seminars |
Luncheon
Seminar53 FUJIFILM Medical Co., Ltd
Frontier of endoscopic tretment for postoperative intestinal cases |
Luncheon
Seminar54 Gilead Sciences, Inc.
What is the new Hepatitis C treatment strategies in the IFN-free era? |
Luncheon
Seminar55 Novartis Pharma K.K.
Update of Treatment and Diagnosis of Neuroendocrine Tumor |
Luncheon
Seminar56 Astellas Pharma Inc. / Zeria Pharmaceutical Co., Ltd.
The forefront of the research for gastric symptom generation |
Luncheon
Seminar57 DAIICHI SANKYO CO., LTD / AstraZeneca K.K.
Future Direction of Treatment for Acid Related Disease |
Luncheon
Seminar58 Kyorin Pharmaceutical Company, Limited
Review the management of ulcerative colitis from the female point of view |
Luncheon
Seminar59 AbbVie GK / EA Pharma Co., Ltd
Consider again about long term management of Crohn’s disease. |
Luncheon
Seminar60 ZERIA Pharmaceutical Co., Ltd. / Kyowa Hakko Kirin Co., Ltd.
Essential treatment of ulcerative colitis; focus on 5-ASA medication |
Luncheon
Seminar61 EA Pharma Co., Ltd.
“Lessons from conventional therapy” Considering current IBD treatment |
Luncheon
Seminar62 Shire Japan KK
Current situation and issue of short bowel syndrome treatment - from Intestinal Failure in Children to Crohn's disease |
13:00 |
| 40 |
|
|
|
|
40 |
| 14:00 |
|
|
|
|
|
|
|
|
|
|
|
|
|
14:00 |
| 30 |
|
Special Lecture (JGES)
Helicobacter pylori and gastric cancer M. Kodama
Chair: M. Kato |
S6 (JSGE / JGES / JSH / JSGS / JSGCS)
Recent progress in clinical management of sclerosing cholangitis Chair: K. Inui
S. Tazuma |
Invited Lecture (JGES)
Video journalism for endoscopists G. S. Raju
Chair: T. Joh |
W18 (JGES / JSGS)
What would you do? Troubleshooting and prevention of complications associated with ERCP and EUS Chair: T. Ohtsuka
M. Toki |
Integrated Program 6(PD) (JDDW (JSH / JSGE / JGES / JSGS))
How is obesity treated? Chair: E. Hashimoto
Y. Kitagawa
Y. Kinoshita |
PD15 (JSGS / JSGE / JGES)
The treatment strategy for pancreatic and gastrointestinal NET <Answer pad> Chair: T. Aoki
A. Kudo |
S8 (JSGS)
Robotic and laparoscopic surgery <Video> Chair: T. Watanabe
I. Uyama |
Invited Lecture (JGES)
Present status and future perspective of advanced diagnostic endoscopy in the colorectum H. Kashida
Chair: S. Kudo |
Seminar on Medical Issues (JDDW)
Handling of subspecialty in medical board in Japan H. Yoshimura
S. Miyazaki
K. Hakamada
H. Takikawa
N. Uemura
Y. Sasaki
Chair: H. Tajiri
T. Shimosegawa |
Medicalstaff Program2 (JDDW)
Team-approached medicine in the treatment/care for patients with intractable GI diseases Chair: T. Chiba
Y. Yabushita |
W20 (JSGE / JSH / JSGS / JSGCS)
Development and clinical application of biomarker of gastroenterological cancer Chair: H. Fujii
M. Muto |
Live broadcast
Room |
Live broadcast
Room |
|
| Digital Poster Session (JSGS) |
14:00 | 16:30 |
| Digital Poster Session (JGES) |
14:00 | 16:30 |
| Digital Poster Session (JSGS) |
14:00 | 16:30 |
30 |
| 40 |
PD11 (JGES / JSGE / JSGCS)
Role of gastrointestinal endoscopists in the eradication of gastric cancer Chair: Y. Naito
T. Arisawa |
IS-PD2 (JGES / JSGE / JSGCS)
Advanced diagnostic endoscopy in lower GI: Future perspective of screening colonoscopy<JGES Featured Session> Chair: S. Oka
R. Shimoda |
40 |
| 15:00 |
PD13 (JGES / JSGE / JSGCS)
Cold polypectomy; Treatment merit and role in colorectal polyps Chair: O. Tsuruta
S. Ogata |
15:00 |
| 16:00 |
|
|
16:00 |
| 30 |
|
|
30 |
| 17:00 |
|
|
|
17:00 |
| 30 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
30 |
| 18:00 |
Satellite
Symposium83 AbbVie GK
Treatment strategy for hepatitis C in the new era with interferon-free regimen
- Evidence and future perspective - |
Satellite
Symposium84 DAIICHI SANKYO CO., LTD / AstraZeneca K.K.
Endoscopic Diagnosis and Treatment for Gastric Tumor |
Satellite
Symposium85 Boston Scientific Japan K.K.
Seek the trend of the strategy for malignant biliary obstruction -Present status and future prospects of metallic stenting- |
No planned seminars |
No planned seminars |
Setting up the JDDW Banquet Room |
Satellite
Symposium86 Covidien Japan Inc.
Positioning of Small Bowel Capsule Endoscopy in Crohn’s Disease –Insights from Japanese Mega Study "J-POP"- |
Satellite
Symposium87 Takeda Pharmaceutical Company Limited / Otsuka Pharmaceutical Co., Ltd.
New recommendations on therapeutic strategy for reflux esophagitis: Focus on vonoprazan |
Satellite
Symposium88 OLYMPUS CORPORATION
Stenting Strategy -Explore the capability of lasercut stent- |
Satellite
Symposium89 PENTAX Medical, HOYA Corporation
Strategy for Hemostasis Using a New Bipolar Hemostasis forceps |
Satellite
Symposium90 Eli Lilly Japan K.K.
Interpreting clinical trial data in the real world –from the perspective view of actual usage experience of RAM+PTX as 2nd line gastric cancer chemotherapy– |
Satellite
Symposium91 Janssen Pharmaceutical K.K.
Clinical practice for autoimmune disorders in the Biologics era - From perspective of gastroenterology, rheumatology, and dermatology |
Satellite
Symposium92 Yoshida Pharmaceutical Co. Ltd.
New Trend of Disorders of the Lower Gastrointestinal Function Based on Rome IV |
18:00 |
| 30 |
|
|
|
|
30 |
| 19:00 |
|
|
|
|
|
|
19:00 |
| 30 |
|
|
|
Social Gathering (after the Satellite Seminar) |
|
|
|
|
|
|
|
|
|
|
30 |
| 20:00 |
|
|
|
20:00 |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
